- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1KS: 4-fluoro-N-methyl-N-{1-[4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl]piperidin-4-yl}-2-(trifluoromethyl)benzamide(Non-covalent)
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.2: 7 residues within 4Å:- Chain A: E.367, R.371, I.374, F.375, L.378, A.451, T.454
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.375, A:A.451
- Hydrogen bonds: A:R.371
- Salt bridges: A:R.371
OLC.3: 9 residues within 4Å:- Chain A: Y.317, R.318, A.321, L.325, A.326, G.329, L.330, F.394
- Chain B: A.297
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:L.325
- Hydrogen bonds: A:Y.317, A:Y.317, A:R.318, B:A.297
OLC.4: 5 residues within 4Å:- Chain A: S.388, F.391, Y.392, F.395, N.396
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.391
- Hydrogen bonds: A:N.396
OLC.11: 8 residues within 4Å:- Chain B: D.207, G.208, A.209, E.212, I.213, S.233, I.237, I.240
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:I.237, B:I.240
- Hydrogen bonds: B:D.207
- Water bridges: B:S.233
OLC.12: 4 residues within 4Å:- Chain B: Y.153, L.436, K.439, F.443
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:K.439, B:F.443, B:F.443, B:F.443
- Salt bridges: B:K.439
- 3 x OLA: OLEIC ACID(Non-covalent)
OLA.5: 11 residues within 4Å:- Chain A: I.199, L.202, A.203, M.206, D.207, G.208, A.209, E.212, I.236, I.237, I.240
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.202, A:A.203, A:A.209, A:E.212, A:I.236, A:I.237, A:I.240
OLA.6: 4 residues within 4Å:- Chain A: V.239, Y.243, H.281, W.285
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.239, A:Y.243, A:Y.243, A:W.285
- Salt bridges: A:H.281
OLA.13: 4 residues within 4Å:- Chain A: L.282
- Chain B: I.333, Y.337, F.338
6 PLIP interactions:1 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:L.282, B:Y.337, B:Y.337, B:F.338
- Hydrogen bonds: B:Y.337, B:Y.337
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.7: 6 residues within 4Å:- Chain A: P.140, L.141, F.142, T.143, I.429, R.432
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.432
PEG.14: 4 residues within 4Å:- Chain B: E.212, T.231, L.232, S.233
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.212, B:E.212, B:L.232
- Water bridges: B:S.233
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, C. et al., Structure of the human smoothened receptor bound to an antitumour agent. Nature (2013)
- Release Date
- 2013-04-24
- Peptides
- Soluble cytochrome b562, Smoothened homolog: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1KS: 4-fluoro-N-methyl-N-{1-[4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl]piperidin-4-yl}-2-(trifluoromethyl)benzamide(Non-covalent)
- 5 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 3 x OLA: OLEIC ACID(Non-covalent)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, C. et al., Structure of the human smoothened receptor bound to an antitumour agent. Nature (2013)
- Release Date
- 2013-04-24
- Peptides
- Soluble cytochrome b562, Smoothened homolog: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.